Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Neovascularization”

300 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 300 results

Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Not applicableStudy completedNCT01010997
What this trial is testing

Foresee Home for Monitoring Age Related Macular Degeneration (AMD)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 10
Not applicableStudy completedNCT00359008
What this trial is testing

PHP Home Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization (CNV)

Who this might be right for
Age Related Macular Degeneration
Notal Vision Ltd. 336
Not applicableStudy completedNCT00088192
What this trial is testing

Intravitreous Pegaptanib Sodium Injection in Patients With Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Eyetech Pharmaceuticals
Not applicableStudy completedNCT04650672
What this trial is testing

Daily Testing at Home by NV-AMD Subjects With Notal Home OCT.

Who this might be right for
Retinal Neovascularization
Notal Vision Inc. 15
Testing effectiveness (Phase 2)Ended earlyNCT01021956
What this trial is testing

Safety and Preliminary Efficacy Study of WST11 (Stakel®)-Mediated VTP Therapy in Subjects With CNV Associated With AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Steba Biotech S.A. 10
Testing effectiveness (Phase 2)Ended earlyNCT02387957
What this trial is testing

A 24 Month Phase 2a Open Label, Randomized Study of Avastin®, Lucentis®, or Eylea® (Anti-VEGF Therapy) Administered in Combination With Fovista® (Anti-PDGF BB Pegylated Aptamer)

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 63
Testing effectiveness (Phase 2)WithdrawnNCT01015495
What this trial is testing

Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid Streaks

Who this might be right for
Angioid Streaks
University of Illinois at Chicago
Post-approval studies (Phase 4)Study completedNCT00556348
What this trial is testing

Intravitreal Bevacizumab for Choridal Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Instituto de Olhos de Goiania 500
Not applicableStudy completedNCT02287298
What this trial is testing

Triple Combination Therapy of Choroidal Neovascularization in AMD, a Cost Effect and Efficient Therapeutic Treatment

Who this might be right for
Exudative Macular Degeneration
The Retina Center of St. Louis County, PC 400
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Not applicableLooking for participantsNCT07255859
What this trial is testing

CRYSTALSIGHT Cohort 2.0

Who this might be right for
Maculopathy
Tan Tock Seng Hospital 60
Not applicableUnknownNCT03838679
What this trial is testing

Imaging of the Angiofibrotic Switch in Neovascular AMD

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascularization
Medical University of Vienna 120
Not applicableWithdrawnNCT00618644
What this trial is testing

Ranibizumab for Neovascularization in Sickle Cell Retinopathy

Who this might be right for
Sickle Cell AnemiaRetinopathy
Kresge Eye Institute
Testing effectiveness (Phase 2)UnknownNCT04504123
What this trial is testing

MMP-9 Inhibition for Recalcitrant Wet AMD

Who this might be right for
Exudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa 50
Not applicableStudy completedNCT00417846
What this trial is testing

Age-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)

Who this might be right for
Maculopathy, Age-RelatedChoroidal Neovascularization
Johns Hopkins University 98
Large-scale testing (Phase 3)Study completedNCT00150202
What this trial is testing

Clinical Study Of EYE001 For Wet-Type AMD (Age-Related Macular Degeneration)

Who this might be right for
Macular Degeneration
Pfizer 90
Large-scale testing (Phase 3)UnknownNCT00517257
What this trial is testing

Atorvastatin for the Treatment of Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionRetinal Vein ThrombosisCentral Retinal Vein Occlusion+2 more
University of Toronto 180
Large-scale testing (Phase 3)Study completedNCT00523406
What this trial is testing

Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate)

Who this might be right for
Macular Degeneration
Medical University of Vienna 40
Large-scale testing (Phase 3)Study completedNCT04964089
What this trial is testing

Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 557
Load More Results